
SKIN Stock Forecast & Price Target
SKIN Analyst Ratings
Bulls say
SkinHealth Systems is a world-wide leader in medical aesthetics, with a strong focus on delivering clinically validated solutions for superior skin health. Despite facing regulatory risks and competition from larger operators, the company has shown strong financial performance with consistent beats on revenue and EBITDA, as well as tight control of operating expenses. With a new CEO at the helm and plans to launch new products in the coming years, the company continues to show potential for growth and success.
Bears say
SkinHealth Systems is facing several challenges that may impact its financial performance in the near term. These include their key patents expiring in 2026, ongoing litigation obligations, and intense competition in the rapidly changing skincare market. Additionally, the majority of their sales come from their Hydrafacial platform, making them vulnerable to negative events or declines in demand. Regulatory approval processes and any delays could also significantly impact the company's operations and financial results. Overall, these factors make me cautious about the company's future prospects and lead me to have a negative outlook on their stock.
This aggregate rating is based on analysts' research of The Beauty Health Company and is not a guaranteed prediction by Public.com or investment advice.
SKIN Analyst Forecast & Price Prediction
Start investing in SKIN
Order type
Buy in
Order amount
Est. shares
0 shares